Ketamine for Chronic Pain: How At-Home Treatment Works

Chronic pain changes your brain. That is not a metaphor or an oversimplification. When pain persists for months or years, the nervous system undergoes structural and chemical changes that amplify pain signals, reduce the effectiveness of the body's natural pain-control mechanisms, and --- critically --- create overlapping pathways with depression and anxiety.

As a physician treating patients with both chronic pain and mood disorders, I have seen how deeply these conditions intertwine. Many of my patients have spent years cycling through pain medications, antidepressants, physical therapy, and specialist visits without finding meaningful relief. Ketamine therapy offers a fundamentally different approach because it targets the specific neural mechanisms that sustain both chronic pain and depression simultaneously.

The Pain-Depression Overlap

If you live with chronic pain, you likely already know that it affects your mood, your sleep, your relationships, and your ability to function. What you may not know is that pain and depression are not just commonly co-occurring conditions --- they share biological machinery at the deepest levels of brain function.

Both chronic pain and depression involve dysregulation of the glutamate system, the brain's primary excitatory neurotransmitter network. In chronic pain states, glutamate signaling becomes overactive, leading to a phenomenon called central sensitization, where the nervous system amplifies pain signals even when the original tissue injury has healed or when no injury exists at all. This same glutamate dysregulation plays a central role in treatment-resistant depression.

Understanding how ketamine works helps clarify why it can address both conditions. Ketamine is an NMDA receptor antagonist, meaning it modulates the glutamate system directly. This is what makes it fundamentally different from opioids, NSAIDs, gabapentinoids, and traditional antidepressants.

NMDA Receptors and Pain Signaling

NMDA receptors are found throughout the brain and spinal cord. Under normal circumstances, they play essential roles in learning, memory, and synaptic plasticity. But in chronic pain states, these receptors become chronically activated, contributing to several problematic processes.

Central sensitization occurs when repeated pain signals cause NMDA receptors in the spinal cord to become hyperexcitable. This means that stimuli that should not be painful --- light touch, mild pressure, normal movement --- begin to register as pain. Patients with fibromyalgia, chronic regional pain syndrome (CRPS), and neuropathic pain conditions often experience this phenomenon.

Wind-up is a related process in which repeated stimulation of pain fibers causes a progressive increase in the intensity of perceived pain. Each signal builds on the last, creating escalating pain from a constant stimulus. NMDA receptor activation is a key driver of this process.

Maladaptive neuroplasticity describes the long-term structural changes in the nervous system that sustain chronic pain. Just as healthy neuroplasticity allows the brain to learn and adapt, maladaptive plasticity locks the nervous system into patterns of amplified pain signaling.

By blocking NMDA receptors, ketamine can interrupt all three of these processes. This is not about numbing the pain temporarily. It is about resetting the neural circuits that have become stuck in a pain-amplifying state.

Conditions That May Respond to Ketamine

Research and clinical experience suggest that ketamine therapy may benefit patients with several chronic pain conditions, particularly those involving central sensitization.

Fibromyalgia is characterized by widespread musculoskeletal pain, fatigue, and cognitive difficulties. Central sensitization is thought to be a primary driver of fibromyalgia symptoms, making it a particularly promising target for ketamine's NMDA receptor modulation.

Neuropathic pain results from damage or dysfunction in the nerves themselves. Conditions such as diabetic neuropathy, post-herpetic neuralgia (shingles-related pain), and chemotherapy-induced peripheral neuropathy involve NMDA receptor-mediated changes in the way pain signals are processed.

Complex regional pain syndrome (CRPS) is among the most debilitating chronic pain conditions. It typically develops after an injury and involves pain that is disproportionate to the initial trauma, along with changes in skin color, temperature, and swelling. Ketamine has been studied extensively for CRPS, with some patients experiencing significant and lasting relief.

Chronic migraine and certain headache disorders may also respond to ketamine therapy, particularly when they co-occur with depression or have proven resistant to conventional treatments.

It is important to note that ketamine therapy is not appropriate for all types of pain. Acute pain from a recent injury, cancer-related pain requiring palliative care, and pain that has a surgically correctable cause generally require different approaches. During your evaluation, we assess your specific pain condition to determine whether ketamine is likely to help. You can review our safety guidelines for more details on who is and is not a good candidate.

Dosing for Pain Versus Depression

One of the questions I am asked most frequently is whether dosing for chronic pain differs from dosing for depression. The answer is nuanced.

For depression, sublingual ketamine at the doses we prescribe for at-home therapy has strong evidence supporting its effectiveness. The neuroplastic changes that improve mood typically begin at relatively modest doses and build over a series of sessions.

For chronic pain, particularly conditions involving significant central sensitization, some patients benefit from a slightly different dosing approach. Pain-related NMDA receptor changes can sometimes require more sustained exposure to achieve a meaningful reset. However, at-home sublingual therapy has shown meaningful results for many chronic pain patients, especially when pain co-occurs with depression.

The at-home treatment model offers a distinct advantage for pain patients: consistency. Chronic pain is not an episodic condition. It is present every day, and the neural patterns that sustain it require consistent intervention to shift. With at-home therapy, you can maintain a regular treatment schedule without the burden of traveling to a clinic while in pain --- which, for many chronic pain patients, is a significant barrier to receiving any treatment at all.

We carefully titrate dosing based on your specific condition, your response to treatment, and any other medications you are taking. Learn more about what to expect during the treatment process.

The Advantage of Treating Pain and Depression Together

Traditional medicine often silos chronic pain and depression into separate treatment tracks. You see a pain specialist who prescribes one set of medications, and a psychiatrist who prescribes another. The two rarely communicate, and you are left managing a growing list of prescriptions that may interact with each other in unpredictable ways.

Ketamine therapy addresses both conditions through a single mechanism. When a patient comes to me with fibromyalgia and major depression, I do not need to choose which condition to treat first. The same NMDA receptor modulation that promotes synaptic growth and reduces depressive rumination also reduces central sensitization and interrupts maladaptive pain signaling.

Patients frequently report that as their mood improves, their relationship with pain changes. Pain may not disappear entirely, but it becomes more manageable. The catastrophizing thoughts that amplify pain --- the sense that the pain will never end, that nothing will help --- begin to loosen their grip. This is not wishful thinking. It is the result of neuroplastic changes in the brain circuits that process both emotion and pain.

What At-Home Treatment Looks Like

At-home ketamine therapy for chronic pain follows the same general structure as treatment for depression. After an initial evaluation where we review your medical history, current medications, and specific pain condition, you receive sublingual ketamine tablets that you take at home on a prescribed schedule.

Each session lasts approximately one to two hours, during which you rest in a comfortable, quiet environment. Many chronic pain patients tell me that the sessions themselves provide a welcome break from the constant experience of pain, even before the longer-term therapeutic effects become apparent.

We monitor your progress through regular check-ins, adjusting your treatment plan as needed based on your pain levels, mood, and functional capacity. Understanding the cost structure upfront helps you plan for sustained treatment, which is particularly important for chronic pain management.

Taking the First Step

Living with chronic pain is exhausting. It wears down your body, your mind, and your hope that things can improve. If you have tried multiple treatments without adequate relief, ketamine therapy may offer a new path forward --- one that targets the underlying neural mechanisms of pain rather than simply masking symptoms.

I encourage you to check your eligibility to find out whether at-home ketamine therapy is right for your chronic pain condition. You deserve a treatment approach that sees the full picture of what you are experiencing, and that works to address it at its source.